Tokyo - Delayed Quote JPY
Delta-Fly Pharma, Inc. (4598.T)
647.00
+44.00
+(7.30%)
At close: May 30 at 3:30:00 PM GMT+9
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
-1,279,615
-1,279,615
-1,303,049
-940,399
-726,649
Investing Cash Flow
207
207
-326
0
-505
Financing Cash Flow
1,853,195
1,853,195
882,617
119,857
875,313
End Cash Position
1,417,062
1,417,062
844,341
1,268,492
2,088,612
Capital Expenditure
-1,132
-1,132
-321
--
-505
Issuance of Capital Stock
1,849,479
1,849,479
878,681
120,030
875,042
Issuance of Debt
0
0
400,000
0
--
Repayment of Debt
0
0
-400,000
0
-5,700
Repurchase of Capital Stock
0
0
-37
-173
0
Free Cash Flow
-1,280,747
-1,280,747
-1,303,370
-940,399
-727,154
3/31/2021 - 10/12/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade